Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review - PubMed (original) (raw)

Review

Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review

A Natali et al. Diabetologia. 2006 Mar.

Abstract

Aims/hypothesis: Insulin resistance, which manifests itself as endogenous glucose overproduction and reduced insulin-mediated glucose uptake, is a core defect in type 2 diabetes. Metformin and the peroxisome proliferator-activated receptor-gamma agonists, the thiazolidinediones (TZDs), both lower glucose, although their mechanism of action is still subject to debate. This review analyses the evidence relevant to these mechanisms in vivo.

Materials and methods: A systematic search of MEDLINE identified a total of 42 clinical studies that investigated the effects of TZDs (n=23) and/or metformin (n=19) on endogenous glucose production (using tracer glucose techniques) and peripheral glucose disposal (using the euglycaemic-hyperinsulinaemic clamp) in patients with type 2 diabetes (n=549). The original variables assessed were converted into standardised units and their mean group values were listed separately for open and placebo-controlled studies. Statistical analysis was scarried out, treating mean group values as individual values and comparing results (both as absolute values and percentage changes from baseline) across study categories (open vs placebo-controlled, TZDs vs metformin).

Results: Both TZDs and metformin enhance insulin suppression of endogenous glucose production and fasting plasma glucose clearance. TZDs, but not metformin, also improve insulin-mediated glucose uptake at all insulin levels.

Conclusions/interpretation: In patients with type 2 diabetes, metformin improves fasting hepatic insulin sensitivity and glucose clearance; TZDs improve fasting hepatic insulin sensitivity and glucose clearance, and potentiate glucose disposal under insulinised conditions.

PubMed Disclaimer

Cited by

Myoinositol and Metformin in the Prevention of Gestational Diabetes in High-Risk Patients: A Narrative Review.
Romeo P, D'Anna R, Corrado F. Romeo P, et al. J Clin Med. 2024 Sep 12;13(18):5387. doi: 10.3390/jcm13185387. J Clin Med. 2024. PMID: 39336874 Free PMC article. Review.
Effective interventions in preventing gestational diabetes mellitus: A systematic review and meta-analysis.
Takele WW, Vesco KK, Josefson J, Redman LM, Hannah W, Bonham MP, Chen M, Chivers SC, Fawcett AJ, Grieger JA, Habibi N, Leung GKW, Liu K, Mekonnen EG, Pathirana M, Quinteros A, Taylor R, Ukke GG, Zhou SJ; ADA/EASD PMDI; Lim S. Takele WW, et al. Commun Med (Lond). 2024 Apr 20;4(1):75. doi: 10.1038/s43856-024-00491-1. Commun Med (Lond). 2024. PMID: 38643248 Free PMC article.
Glycemia and Gluconeogenesis With Metformin and Liraglutide: A Randomized Trial in Youth-onset Type 2 Diabetes.
Dietsche KB, Magge SN, Dixon SA, Davis FS, Krenek A, Chowdhury A, Mabundo L, Stagliano M, Courville AB, Yang S, Turner S, Cai H, Kasturi K, Sherman AS, Ha J, Shouppe E, Walter M, Walter PJ, Chen KY, Brychta RJ, Peer C, Zeng Y, Figg W, Cogen F, Estrada DE, Chacko S, Chung ST. Dietsche KB, et al. J Clin Endocrinol Metab. 2024 Apr 19;109(5):1361-1370. doi: 10.1210/clinem/dgad669. J Clin Endocrinol Metab. 2024. PMID: 37967247 Free PMC article. Clinical Trial.
Impact of Fixed Combination of Metformin and Pioglitazone on Insulin Resistance of Patients with Type 2 Diabetes: Results of a Randomized Open-Label Study.
Sun R, Yuan L, Shen Y, Shen Z, Ding B, Ma J. Sun R, et al. Diabetes Metab Syndr Obes. 2023 Sep 20;16:2911-2919. doi: 10.2147/DMSO.S423322. eCollection 2023. Diabetes Metab Syndr Obes. 2023. PMID: 37753480 Free PMC article. Clinical Trial.
Review of the Case Reports on Metformin, Sulfonylurea, and Thiazolidinedione Therapies in Type 2 Diabetes Mellitus Patients.
Susilawati E, Levita J, Susilawati Y, Sumiwi SA. Susilawati E, et al. Med Sci (Basel). 2023 Aug 15;11(3):50. doi: 10.3390/medsci11030050. Med Sci (Basel). 2023. PMID: 37606429 Free PMC article. Review.

References

1. Diabetes. 1985 Mar;34(3):222-34 - PubMed
1. Diabetes. 2005 May;54(5):1459-67 - PubMed
1. Diabetes. 1999 Dec;48(12):2414-21 - PubMed
1. Diabete Metab. 1994 Nov-Dec;20(6):532-9 - PubMed
1. J Clin Endocrinol Metab. 2003 Apr;88(4):1637-45 - PubMed

Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review - PubMed (original) (raw)